Allele frequencies of BRAFV600 mutations in primary melanomas and matched metastases and their relevance for BRAF inhibitor therapy in metastatic melanoma
about
Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry.Intratumor and Intertumor Heterogeneity in Melanoma.Reply to "Clinical and therapeutic implications of BRAF mutation heterogeneity in metastatic melanoma" by Mesbah Ardakani et al.Polo-like kinase-1 immunoreactivity is associated with metastases in cutaneous melanoma.
P2860
Allele frequencies of BRAFV600 mutations in primary melanomas and matched metastases and their relevance for BRAF inhibitor therapy in metastatic melanoma
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Allele frequencies of BRAFV600 ...... therapy in metastatic melanoma
@ast
Allele frequencies of BRAFV600 ...... therapy in metastatic melanoma
@en
type
label
Allele frequencies of BRAFV600 ...... therapy in metastatic melanoma
@ast
Allele frequencies of BRAFV600 ...... therapy in metastatic melanoma
@en
prefLabel
Allele frequencies of BRAFV600 ...... therapy in metastatic melanoma
@ast
Allele frequencies of BRAFV600 ...... therapy in metastatic melanoma
@en
P2093
P2860
P356
P1433
P1476
Allele frequencies of BRAFV600 ...... therapy in metastatic melanoma
@en
P2093
Bernd Timmermann
Bernward Völker
Carola Berking
Imke Satzger
Lena Marks
Ralf Gutzmer
Rudolf Herbst
Sven Klages
Vivien Schacht
P2860
P304
37895-37905
P356
10.18632/ONCOTARGET.5634
P407
P577
2015-10-16T00:00:00Z